Lessons Learned From Shared Decision-Making With OralAnticoagulants:Viewpoint on Suggestions for the Developmentof Oral Chemotherapy Decision Aids

被引:0
|
作者
McLoughlin, Daniel E. [1 ]
Echevarria, Fabiola M. Moreno [1 ]
Badawy, Sherif M. [1 ,2 ]
机构
[1] Northwestern Univ, Feinberg Sch Med, 420 E Super St, Chicago, IL 60611 USA
[2] Ann & Robert H Lurie Childrens Hosp Chicago, Div Hematol Oncol & Stem Cell Transplant, Chicago, IL USA
来源
JMIR CANCER | 2024年 / 10卷
关键词
shared decision-making; SDM; decision aids; decision aids design; oral chemotherapy; oral anticoagulants; drug delivery; chemotherapy; chemo; anticoagulants; drug deliveries; cancer; oncology; oncologist; metastases; literature review; literature reviews; ADJUVANT CHEMOTHERAPY; INFORMATION; PROVIDERS; LIFE;
D O I
10.2196/56935
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Oral chemotherapy is commonly prescribed, and by using decision aids (DAs), clinicians can facilitate shared decision-making(SDM) to align treatment choices with patient goals and values. Although products exist commercially, little evidence informsthe development of DAs targeting the unique challenges of oral chemotherapy. To address this gap in the literature, our objectivewas to review DAs developed for oral anticoagulation, DA use in oncology, and patient preference surveys to guide the developmentof DAs for oral chemotherapy. We focused on reviewing SDM, patient preferences, and specifically the development, efficacy,and patient experience of DAs in oral anticoagulation and oncologic conditions, ultimately including conclusions and data from30 peer-reviewed publications in our viewpoint paper. We found that effective DAs in oral anticoagulation improved knowledge,lowered decisional conflict, increased adherence, and covered a broad range of SDM elements; however, limited information onpatient experience was a common shortcoming. In oncology, DAs increased knowledge and aligned decisions with the values ofthe patients. Ineffective oncology DAs provided general, unclear, or overly optimistic information, while providing "too much"information was not shown to do harm. Patients preferred DAs that included pros and cons, side effects, questions to ask, andexpected quality of life changes. In developing DAs for oral chemotherapy, patients should be included in the developmentprocess, and DA content should be specifically tailored to patient preferences. Providing DAs ahead of appointments provedmore effective than during, and additional considerations included addressing barriers to efficacy. There is a need for evidence-basedDAs to facilitate SDM for patients considering oral chemotherapy. Developers should use data from studies in oral anticoagulation,oncology, and preference surveys to optimize SDM.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] Decision-making in localized prostate cancer: lessons learned from an online support group
    Huber, Johannes
    Ihrig, Andreas
    Peters, Tim
    Huber, Christian G.
    Kessler, Anja
    Hadaschik, Boris
    Pahernik, Sascha
    Hohenfellner, Markus
    BJU INTERNATIONAL, 2011, 107 (10) : 1570 - 1575
  • [32] The application of mathematical techniques for modeling decision-making: Lessons learned from a preliminary study
    Campbell, GE
    Buff, WL
    Bolton, AE
    Holness, DO
    ICCM - 2001: PROCEEDINGS OF THE 2001 FOURTH INTERNATIONAL CONFERENCE ON COGNITIVE MODELING, 2001, : 49 - 54
  • [33] Improving Shared Decision-making in Situations of Uncertainty: Adopting Lessons From "The Equipoise Ruler"
    Brindle, Mary E.
    ANNALS OF SURGERY, 2024, 280 (06) : 914 - 915
  • [34] Integrating shared decision-making into primary care: lessons learned from a multi-centre feasibility randomized controlled trial
    Catherine H. Yu
    Farid Medleg
    Dorothy Choi
    Catherine M. Spagnuolo
    Lakmini Pinnaduwage
    Sharon E. Straus
    Paul Cantarutti
    Karen Chu
    Paul Frydrych
    Amy Hoang-Kim
    Noah Ivers
    David Kaplan
    Fok-Han Leung
    John Maxted
    Jeremy Rezmovitz
    Joanna Sale
    Sumeet Sodhi
    Dawn Stacey
    Deanna Telner
    BMC Medical Informatics and Decision Making, 21
  • [35] Integrating shared decision-making into primary care: lessons learned from a multi-centre feasibility randomized controlled trial
    Yu, Catherine H.
    Medleg, Farid
    Choi, Dorothy
    Spagnuolo, Catherine M.
    Pinnaduwage, Lakmini
    Straus, Sharon E.
    Cantarutti, Paul
    Chu, Karen
    Frydrych, Paul
    Hoang-Kim, Amy
    Ivers, Noah
    Kaplan, David
    Leung, Fok-Han
    Maxted, John
    Rezmovitz, Jeremy
    Sale, Joanna
    Sodhi, Sumeet
    Stacey, Dawn
    Telner, Deanna
    BMC MEDICAL INFORMATICS AND DECISION MAKING, 2021, 21 (01)
  • [36] RECOVERY FROM PSYCHOSIS: MEDICATION AND SHARED DECISION-MAKING
    Taylor, M.
    Baune, B.
    Theodoros, T.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2019, 53 : 77 - 78
  • [37] From informed consent to shared decision-making in surgery
    Slim, K.
    Bazin, J. -E.
    JOURNAL OF VISCERAL SURGERY, 2019, 156 (03) : 181 - 184
  • [38] Large language models as decision aids in neuro-oncology: a review of shared decision-making applications
    McLean, Aaron Lawson
    Wu, Yonghui
    McLean, Anna C. Lawson
    Hristidis, Vagelis
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2024, 150 (03)
  • [39] How Do Patient Decision Aids Enable Purposeful Shared Decision-Making in Rheumatology? An Integrative Review
    Oke, Ibiyemi
    Ni, Ruoning
    Kumar, Bharat
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 739 - 742
  • [40] Large language models as decision aids in neuro-oncology: a review of shared decision-making applications
    Aaron Lawson McLean
    Yonghui Wu
    Anna C. Lawson McLean
    Vagelis Hristidis
    Journal of Cancer Research and Clinical Oncology, 150